Aligos Therapeutics, Inc. (ALGS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 92.13M |
| Enterprise Value | 79.07M |
| P/E Ratio | -0.71 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.02 |
| Price/Book Ratio | 1.69 |
| Enterprise/Revenue | 0.16 |
| Enterprise/EBITDA | -0.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.41 |
| Operating Margin | -2.51 |
AD
Management Effectiveness
| Return On Assets | -1.15 |
| Return On Equity | -1.61 |
Income Statement
| Revenue | 2.19M |
| Revenue/Share | 3.02 |
| Gross Profit | 1.26M |
| EBITDA | -22.95M |
| Net Income | -24.19M |
| Diluted EPS | -2.45 |
Balance Sheet
| Total Cash | 30.38M |
| Total Cash/Share | 2.91 |
| Total Debt | 3.5M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 2.19 |
| Book Value Per Share | 3.06 |
Price History
| 52-Week Change | -52.39 |
| 52-Week High | 13.69 |
| 52-Week Low | 3.98 |
| Moving Average 50 Days | 5.92 |
| Moving Average 200 Days | 7.1 |
Statistics
| Average Volume | 168,729 |
| Shares Outstanding | 6.19M |
| % Held by Institutions | 21.98 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 19, 2024 |
AD
